A Fluorescent sp2-Iminosugar With Pharmacological Chaperone Activity for Gaucher Disease: Synthesis and Intracellular Distribution Studies-Reference-Cited by-同舟云学术

A Fluorescent sp2-Iminosugar With Pharmacological Chaperone Activity for Gaucher Disease: Synthesis and Intracellular Distribution Studies

Published:2010-11-09 Issue:17 Volume:11 Page:2453-2464
ISSN:1439-4227
Container-title:ChemBioChem
language:en
Short-container-title:Chem. Eur. J. of Chem. Bio.

Author:

Luan Zhuo,Higaki Katsumi,Aguilar-Moncayo Matilde,Li Linjing,Ninomiya Haruaki,Nanba Eiji,Ohno Kousaku,García-Moreno M. Isabel,Ortiz Mellet Carmen,García Fernández José M.,Suzuki Yoshiyuki

Publisher

Wiley

Subject

Organic Chemistry,Molecular Biology,Molecular Medicine,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cbic.201000323/fullpdf

Reference50 articles.

1. Gaucher disease

2. Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's Disease

3. Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis

4. Enzyme therapy for Gaucher disease: the first 5 years

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High‐Mannose Oligosaccharide Hemimimetics that Recapitulate the Conformation and Binding Mode to Concanavalin A, DC‐SIGN and Langerin;Chemistry – A European Journal;2023-11-14

2. Serine-/Cysteine-Based sp²-Iminoglycolipids as Novel TLR4 Agonists: Evaluation of Their Adjuvancy and Immunotherapeutic Properties in a Murine Model of Asthma;Journal of Medicinal Chemistry;2023-03-23

3. Synthesis of sp2-Iminosugar Selenoglycolipids as Multitarget Drug Candidates with Antiproliferative, Leishmanicidal and Anti-Inflammatory Properties;Molecules;2021-12-11

4. Small Molecule Chaperones for the Treatment of Gaucher Disease and GBA1-Associated Parkinson Disease;Frontiers in Cell and Developmental Biology;2020-05-19

5. Carbohydrate supramolecular chemistry: beyond the multivalent effect;Chemical Communications;2020